Cargando…

Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents

BACKGROUND: The pathogenic and oncogenic roles of papillomavirus (HPV) infections have been documented and shown to occur in women as well as in men. While other countries have already extended their vaccination guidelines to include boys, in 2019 the French National Authority for Health validated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huon, Jean-François, Grégoire, Antoine, Meireles, Anita, Lefebvre, Maëva, Péré, Morgane, Coutherut, Julie, Biron, Charlotte, Raffi, François, Briend-Godet, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580947/
https://www.ncbi.nlm.nih.gov/pubmed/33091021
http://dx.doi.org/10.1371/journal.pone.0234693
_version_ 1783598875139899392
author Huon, Jean-François
Grégoire, Antoine
Meireles, Anita
Lefebvre, Maëva
Péré, Morgane
Coutherut, Julie
Biron, Charlotte
Raffi, François
Briend-Godet, Valérie
author_facet Huon, Jean-François
Grégoire, Antoine
Meireles, Anita
Lefebvre, Maëva
Péré, Morgane
Coutherut, Julie
Biron, Charlotte
Raffi, François
Briend-Godet, Valérie
author_sort Huon, Jean-François
collection PubMed
description BACKGROUND: The pathogenic and oncogenic roles of papillomavirus (HPV) infections have been documented and shown to occur in women as well as in men. While other countries have already extended their vaccination guidelines to include boys, in 2019 the French National Authority for Health validated implementation of HPV vaccination in the 2020 vaccination schedule. There is, however, a climate of distrust in regard to vaccination in France, and there have been few studies to date regarding the acceptability of HPV vaccination in boys in France. The aim of this study was, therefore, to evaluate the acceptability of extending the recommendations for HPV vaccination in men, among middle and high school students and their parents. METHODS: Our study (HPVac) was a prospective, multicenter, departmental, and descriptive survey applied to a sample of male middle and high school students attending schools in the Loire-Atlantique department and their parents. It took place from January 2017 to January 2018. RESULTS: We analyzed the information obtained from 127 parent questionnaires and 145 children questionnaires. In terms of acceptability, 36.6% (n = 53) of the children and 37.8% (n = 48) of the parents were in favour of being vaccinated or of having their children vaccinated against HPV (51.7% (n = 75) and 50.4% (n = 64), respectively, were undecided). The perception of a risk stemming from HPV infection was positively associated with acceptability of the HPV vaccine. Being against vaccines in general, being discouraged by their parents, parents thinking that their child is not at risk, and the belief that the vaccine is not mandatory were arguments cited and significantly associated with a willingness to be vaccinated. CONCLUSION: This study revealed a lack of information among boys and their parents about HPV and its vaccination. It also clearly showed that taking time to discuss the consequences of an infection and the merits of being vaccinated can help parents overcome their reluctance. The children then generally go along with their parent's choice.
format Online
Article
Text
id pubmed-7580947
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-75809472020-10-27 Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents Huon, Jean-François Grégoire, Antoine Meireles, Anita Lefebvre, Maëva Péré, Morgane Coutherut, Julie Biron, Charlotte Raffi, François Briend-Godet, Valérie PLoS One Research Article BACKGROUND: The pathogenic and oncogenic roles of papillomavirus (HPV) infections have been documented and shown to occur in women as well as in men. While other countries have already extended their vaccination guidelines to include boys, in 2019 the French National Authority for Health validated implementation of HPV vaccination in the 2020 vaccination schedule. There is, however, a climate of distrust in regard to vaccination in France, and there have been few studies to date regarding the acceptability of HPV vaccination in boys in France. The aim of this study was, therefore, to evaluate the acceptability of extending the recommendations for HPV vaccination in men, among middle and high school students and their parents. METHODS: Our study (HPVac) was a prospective, multicenter, departmental, and descriptive survey applied to a sample of male middle and high school students attending schools in the Loire-Atlantique department and their parents. It took place from January 2017 to January 2018. RESULTS: We analyzed the information obtained from 127 parent questionnaires and 145 children questionnaires. In terms of acceptability, 36.6% (n = 53) of the children and 37.8% (n = 48) of the parents were in favour of being vaccinated or of having their children vaccinated against HPV (51.7% (n = 75) and 50.4% (n = 64), respectively, were undecided). The perception of a risk stemming from HPV infection was positively associated with acceptability of the HPV vaccine. Being against vaccines in general, being discouraged by their parents, parents thinking that their child is not at risk, and the belief that the vaccine is not mandatory were arguments cited and significantly associated with a willingness to be vaccinated. CONCLUSION: This study revealed a lack of information among boys and their parents about HPV and its vaccination. It also clearly showed that taking time to discuss the consequences of an infection and the merits of being vaccinated can help parents overcome their reluctance. The children then generally go along with their parent's choice. Public Library of Science 2020-10-22 /pmc/articles/PMC7580947/ /pubmed/33091021 http://dx.doi.org/10.1371/journal.pone.0234693 Text en © 2020 Huon et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Huon, Jean-François
Grégoire, Antoine
Meireles, Anita
Lefebvre, Maëva
Péré, Morgane
Coutherut, Julie
Biron, Charlotte
Raffi, François
Briend-Godet, Valérie
Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents
title Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents
title_full Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents
title_fullStr Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents
title_full_unstemmed Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents
title_short Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents
title_sort evaluation of the acceptability in france of the vaccine against papillomavirus (hpv) among middle and high school students and their parents
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580947/
https://www.ncbi.nlm.nih.gov/pubmed/33091021
http://dx.doi.org/10.1371/journal.pone.0234693
work_keys_str_mv AT huonjeanfrancois evaluationoftheacceptabilityinfranceofthevaccineagainstpapillomavirushpvamongmiddleandhighschoolstudentsandtheirparents
AT gregoireantoine evaluationoftheacceptabilityinfranceofthevaccineagainstpapillomavirushpvamongmiddleandhighschoolstudentsandtheirparents
AT meirelesanita evaluationoftheacceptabilityinfranceofthevaccineagainstpapillomavirushpvamongmiddleandhighschoolstudentsandtheirparents
AT lefebvremaeva evaluationoftheacceptabilityinfranceofthevaccineagainstpapillomavirushpvamongmiddleandhighschoolstudentsandtheirparents
AT peremorgane evaluationoftheacceptabilityinfranceofthevaccineagainstpapillomavirushpvamongmiddleandhighschoolstudentsandtheirparents
AT coutherutjulie evaluationoftheacceptabilityinfranceofthevaccineagainstpapillomavirushpvamongmiddleandhighschoolstudentsandtheirparents
AT bironcharlotte evaluationoftheacceptabilityinfranceofthevaccineagainstpapillomavirushpvamongmiddleandhighschoolstudentsandtheirparents
AT raffifrancois evaluationoftheacceptabilityinfranceofthevaccineagainstpapillomavirushpvamongmiddleandhighschoolstudentsandtheirparents
AT briendgodetvalerie evaluationoftheacceptabilityinfranceofthevaccineagainstpapillomavirushpvamongmiddleandhighschoolstudentsandtheirparents